These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27845776)

  • 1. Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy.
    Breitfeld J; Scholl C; Steffens M; Brandenburg K; Probst-Schendzielorz K; Efimkina O; Gurwitz D; Ising M; Holsboer F; Lucae S; Stingl JC
    Transl Psychiatry; 2016 Nov; 6(11):e950. PubMed ID: 27845776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression and proliferation biomarkers for antidepressant treatment resistance.
    Breitfeld J; Scholl C; Steffens M; Laje G; Stingl JC
    Transl Psychiatry; 2017 Mar; 7(3):e1061. PubMed ID: 28291260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cellular turnover in response to fluoxetine in neuronal precursors derived from human embryonic stem cells.
    Chang EA; Beyhan Z; Yoo MS; Siripattarapravat K; Ko T; Lookingland KJ; Madhukar BV; Cibelli JB
    Int J Dev Biol; 2010; 54(4):707-15. PubMed ID: 19598107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study.
    Probst-Schendzielorz K; Scholl C; Efimkina O; Ersfeld E; Viviani R; Serretti A; Fabbri C; Gurwitz D; Lucae S; Ising M; Paul AM; Lehmann ML; Steffens M; Crisafulli C; Calabrò M; Holsboer F; Stingl J
    Pharmacogenomics; 2015; 16(7):689-701. PubMed ID: 25943212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal.
    Surget A; Wang Y; Leman S; Ibarguen-Vargas Y; Edgar N; Griebel G; Belzung C; Sibille E
    Neuropsychopharmacology; 2009 May; 34(6):1363-80. PubMed ID: 18536703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF; Lane RM; Zhu R; Ying Z
    Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of serotonin-related genes in antidepressant response.
    Peters EJ; Slager SL; McGrath PJ; Knowles JA; Hamilton SP
    Mol Psychiatry; 2004 Sep; 9(9):879-89. PubMed ID: 15052272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients.
    Barakat AK; Scholl C; Steffens M; Brandenburg K; Ising M; Lucae S; Holsboer F; Laje G; Kalayda GV; Jaehde U; Stingl JC
    Transl Psychiatry; 2020 Jul; 10(1):210. PubMed ID: 32612257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.
    Licinio J; O'Kirwan F; Irizarry K; Merriman B; Thakur S; Jepson R; Lake S; Tantisira KG; Weiss ST; Wong ML
    Mol Psychiatry; 2004 Dec; 9(12):1075-82. PubMed ID: 15365580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine add-on therapy improves the depressive behaviors and hippocampal neurogenesis in fluoxetine treatment resistant depressive rats.
    Wang Y; Chang T; Chen YC; Zhang RG; Wang HN; Wu WJ; Peng ZW; Tan QR
    Behav Brain Res; 2013 Sep; 253():206-11. PubMed ID: 23876404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans.
    Gassen NC; Hartmann J; Zschocke J; Stepan J; Hafner K; Zellner A; Kirmeier T; Kollmannsberger L; Wagner KV; Dedic N; Balsevich G; Deussing JM; Kloiber S; Lucae S; Holsboer F; Eder M; Uhr M; Ising M; Schmidt MV; Rein T
    PLoS Med; 2014 Nov; 11(11):e1001755. PubMed ID: 25386878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial.
    Berman RM; Darnell AM; Miller HL; Anand A; Charney DS
    Am J Psychiatry; 1997 Jan; 154(1):37-43. PubMed ID: 8988956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial.
    Zhang WJ; Yang XB; Zhong BL
    J Altern Complement Med; 2009 Aug; 15(8):837-44. PubMed ID: 19678773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct lithium-induced gene expression effects in lymphoblastoid cell lines from patients with bipolar disorder.
    Fries GR; Colpo GD; Monroy-Jaramillo N; Zhao J; Zhao Z; Arnold JG; Bowden CL; Walss-Bass C
    Eur Neuropsychopharmacol; 2017 Nov; 27(11):1110-1119. PubMed ID: 28939162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern analysis of antidepressant response to fluoxetine.
    Fieve RR; Goodnick PJ; Peselow ED; Barouche F; Schlegel A
    J Clin Psychiatry; 1986 Nov; 47(11):560-2. PubMed ID: 3533909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice.
    Li Y; Abdourahman A; Tamm JA; Pehrson AL; Sánchez C; Gulinello M
    Pharmacol Biochem Behav; 2015 Aug; 135():70-82. PubMed ID: 26046533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.